rs199588131
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM2
The NM_000441.2(SLC26A4):c.1983C>A(p.Asp661Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,614,054 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000031 ( 0 hom. )
Consequence
SLC26A4
NM_000441.2 missense
NM_000441.2 missense
Scores
7
8
4
Clinical Significance
Conservation
PhyloP100: -0.378
Genes affected
SLC26A4 (HGNC:8818): (solute carrier family 26 member 4) Mutations in this gene are associated with Pendred syndrome, the most common form of syndromic deafness, an autosomal-recessive disease. It is highly homologous to the SLC26A3 gene; they have similar genomic structures and this gene is located 3' of the SLC26A3 gene. The encoded protein has homology to sulfate transporters. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM1
In a domain STAS (size 194) in uniprot entity S26A4_HUMAN there are 17 pathogenic changes around while only 4 benign (81%) in NM_000441.2
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC26A4 | NM_000441.2 | c.1983C>A | p.Asp661Glu | missense_variant | 17/21 | ENST00000644269.2 | NP_000432.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC26A4 | ENST00000644269.2 | c.1983C>A | p.Asp661Glu | missense_variant | 17/21 | NM_000441.2 | ENSP00000494017 | P1 | ||
SLC26A4 | ENST00000492030.2 | n.270C>A | non_coding_transcript_exon_variant | 2/6 | 5 | |||||
SLC26A4 | ENST00000644846.1 | c.696C>A | p.Asp232Glu | missense_variant, NMD_transcript_variant | 7/10 | ENSP00000494344 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152190Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
6
AN:
152190
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000127 AC: 32AN: 251204Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135758
GnomAD3 exomes
AF:
AC:
32
AN:
251204
Hom.:
AF XY:
AC XY:
15
AN XY:
135758
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461746Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 727182
GnomAD4 exome
AF:
AC:
46
AN:
1461746
Hom.:
Cov.:
31
AF XY:
AC XY:
16
AN XY:
727182
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74462
GnomAD4 genome
AF:
AC:
6
AN:
152308
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
14
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:9Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Pendred syndrome Pathogenic:1Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Pathogenic, no assertion criteria provided | clinical testing | The Core Laboratory in Medical Center of Clinical Research, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine | May 12, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Oct 01, 2021 | NM_000441.1(SLC26A4):c.1983C>A(D661E) is a missense variant classified as a variant of uncertain significance in the context of Pendred syndrome. D661E has been observed in cases with relevant disease (PMID: 25761933, 23185506, 23638949). Functional assessments of this variant are not available in the literature. D661E has been observed in population frequency databases (gnomAD: EAS 0.16%). In summary, there is insufficient evidence to classify NM_000441.1(SLC26A4):c.1983C>A(D661E) as pathogenic or benign. Please note: this variant was assessed in the context of healthy population screening. - |
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 27, 2022 | Variant summary: SLC26A4 c.1983C>A (p.Asp661Glu) results in a conservative amino acid change located in the STAS (Sulphate Transporter and AntiSigma factor antagonist) domain (IPR002645) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00013 in 251204 control chromosomes, predominantly within the East Asian subpopulation at a frequency of 0.0017 in the gnomAD database. This frequency is somewhat lower than the estimated maximum expected for a pathogenic variant in SLC26A4 causing Pendred Syndrome (0.0035), allowing no conclusion about variant significance. The variant, c.1983C>A, has been reported in the literature in multiple heterozygous individuals who were affected with hearing loss (e.g. Schrijver_2006, Yuan_2012, Dahl_2013, Gu_2014, Iwasa_2019) or congenital hypothyroidism with normal hearing (e.g. Fu_2016, Zhang_2021), however, in some of these hearing loss cases co-occurrences with other (potentially) pathogenic biallelic variants in other genes have been reported, which could explain the phenotype (e.g. in the GJB2 gene, in Schrijver_2006 and Dahl_2013; and in the OTOF gene in Iwasa_2019), providing supporting evidence for a benign role. In addition, in a family, the proband who was affected with hearing loss, had two pathogenic SLC26A4 variants in compound heterozygous state, but didn't carry the variant, while the unaffected mother and unaffected sister both carried the c.1983C>A variant in trans with a pathogenic SLC26A4 variant (Yu_2019). On the other hand, a recent publication reported experimental evidence evaluating an impact on protein function, and demonstrated that the p.Asp661Glu variant affected the ion transport function of the protein, but had no effect on the membrane location (Zhang_2021). Furthermore, the Deafness Variation Database (DVD), classified the variant as pathogenic, citing overlapping evidence utilized in the context of this evaluation (Azaiez_2018). Eight submitters have provided clinical-significance assessments for this variant in ClinVar after 2014, and classified the variant as pathogenic (n=1) VUS (n=6), and benign (n=1). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 23, 2010 | Variant classified as Uncertain Significance - Favor Benign. The Asp661Glu varia nt in SLC26A4 has been observed in one Asian individual with hearing loss and re tinal disease. This individual did not have a variant on the second copy of the SLC26A4 gene. Computational analyses (biochemical amino acid properties, homolog y, PolyPhen, SIFT, AlignGVGD) do not provide strong support for or against patho genicity. In summary, the clinical significance of this variant cannot be determ ined at this time; however, given the lack of association between SLC26A4 varian ts and retinal disease, the variant is more likley benign. - |
Autosomal recessive nonsyndromic hearing loss 4 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 26, 2020 | Observed heterozygous with no second SLC26A4 variant in multiple unrelated patients (Yuan et al., 2012; Huang et al., 2018; Fu et al., 2016; Yao et al., 2013); Observed in a patient with hearing loss in published literature who harbored a homozygous variant in the OTOA gene (Iwasa et al., 2019); Observed in trans with a pathogenic variant in the unaffected parent of a patient with hearing loss in published literature; the affected child harbored two SLC26A4 variants and did not inherit D661E (Yu et al., 2019); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 29605365, 21704276, 31095577, 30086623, 23638949, 26886089, 18274916, 16952406, 25761933, 30245029, 23185506, 30762455) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Pathogenic
D;D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
.;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.
REVEL
Pathogenic
Sift
Pathogenic
D;.
Sift4G
Uncertain
D;.
Polyphen
D;D
Vest4
MutPred
Loss of sheet (P = 0.3635);Loss of sheet (P = 0.3635);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at